Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Clin Infect Dis. 2010 Oct 1;51(7):777-84. doi: 10.1086/656232.
The simultaneous emergence of human immunodeficiency virus (HIV)-1 group M and HIV-2 into human populations, circa 1921-1940, is attributed to urbanization and changes in sexual behavior. We hypothesized that the initial dissemination of HIV-1, before sexual transmission predominated, was facilitated by the administration, via reusable syringes and needles, of parenteral drugs against tropical diseases. As proxies for highly lethal HIV-1, we investigated risk factors for hepatitis C virus (HCV) and human T cell lymphotropic virus 1 (HTLV-1) infections, blood-borne viruses compatible with prolonged survival, in an area known in 1936-1950 as the most virulent focus of African trypanosomiasis.
Cross-sectional survey of individuals 55 years and older in Mbimou land and Nola, Central African Republic. Dried blood spots were used for HCV and HTLV-1 serologic testing and nucleic acid detection. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were measured by logistic regression.
The only risk factor for HCV genotype 4 infection was treatment of trypanosomiasis before 1951 (OR, 3.13; 95% CI, 1.38-7.09). HTLV-1 infection was associated with having received 2 injections of pentamidine for trypanosomiasis chemoprophylaxis (adjusted OR, 2.03; 95% CI, 1.01-4.06) and with transfusions (adjusted OR, 2.82; 95% CI, 1.04-7.67). From historical data, we predicted that 59% of Mbimous 65 years and older would report treatment for trypanosomiasis before 1951; only 11% did so.
Treatment of trypanosomiasis before 1951 may have caused iatrogenic HCV transmission. Population-wide half-yearly intramuscular pentamidine for trypanosomiasis chemoprophylaxis in 1947-1953 may have caused iatrogenic HTLV-1 transmission. These and other interventions against tropical diseases could have iatrogenically transmitted SIV(cpz), jump-starting the HIV-1 epidemic. The excess mortality among patients with trypanosomiasis treated before 1951 supports this hypothesis.
人类免疫缺陷病毒 1 型(HIV-1)和 HIV-2 于 1921 年至 1940 年间同时出现在人类群体中,这归因于城市化和性行为的变化。我们假设,在性传播占主导地位之前,通过可重复使用的注射器和针头注射治疗热带疾病的药物,促进了 HIV-1 的最初传播。作为高度致命的 HIV-1 的替代品,我们研究了丙型肝炎病毒(HCV)和人类 T 细胞嗜淋巴细胞病毒 1(HTLV-1)感染的危险因素,这些病毒是与长期存活兼容的血源性病毒,在 1936 年至 1950 年期间,中非共和国姆比穆地区和诺拉被称为非洲锥虫病最致命的焦点。
对中非共和国姆比穆地区和诺拉 55 岁及以上的个体进行横断面调查。使用干血斑进行 HCV 和 HTLV-1 血清学检测和核酸检测。通过逻辑回归测量调整后的优势比(OR)和 95%置信区间(CI)。
HCV 基因型 4 感染的唯一危险因素是 1951 年前接受过锥虫病治疗(OR,3.13;95%CI,1.38-7.09)。HTLV-1 感染与接受 2 次喷他脒预防锥虫病(调整后的 OR,2.03;95%CI,1.01-4.06)和输血(调整后的 OR,2.82;95%CI,1.04-7.67)有关。从历史数据来看,我们预测 59%的姆比穆 65 岁及以上的人会报告在 1951 年前接受过锥虫病治疗;但只有 11%的人这样做。
1951 年前接受锥虫病治疗可能导致医源性 HCV 传播。1947 年至 1953 年期间,为预防锥虫病而每半年肌内注射喷他脒可能导致医源性 HTLV-1 传播。这些和其他针对热带疾病的干预措施可能会无意中传播 SIV(cpz),从而引发 HIV-1 疫情。1951 年前接受锥虫病治疗的患者的超额死亡率支持这一假设。